<p>A – Protection afforded by passive immunization. Mice (n = 8–10 mice/group) were treated with the indicated dose of mAb and challenged 18 h later via the intratracheal route with 10 LD<sub>50</sub> of <i>B. anthracis</i> spores (Ames). Statistical comparison of survival of mAb-treated mice vs. control mice given DPBS alone was done with Fisher exact test; * <i>P</i><0.05. B – Capsule reaction produced by incubation of <i>B. anthracis</i> vegetative cells with mAbs of each subclass (75 µg/ml). Red arrow – outer rim produced on binding of IgG3 mAb; blue arrow – inner binding reaction of IgG3 near the cell wall.</p
<p>WT and STAT1<sup>−/−</sup> mice were infected with 10<sup>8</sup> spores <i>B.anthracis</i> intra...
<p>(A–E) Antibody titers elicited by vaccination with DM-C. Six mice per groups were vaccinated with...
Immunoglobulin G3 (IgG3) is the predominant IgG subclass elicited in response to polysaccharide anti...
BALB/c mice were administered (i.p.) once the indicated mAbs (150 μg/mouse in 0.5 mL 0.9% NaCl) or 0...
<p>mAbs were administered by the i.p. route at the doses (µg) listed. Intranasal challenge was perfo...
Bacterial capsules are common targets for antibody-mediated immunity. The capsule of Bacillus anthra...
<p>A/J mice were immunized with either: adjuvant control (*), PA-Av/IFA (○), PA-Av-Alum (□), or PA-A...
<p>Ten mice in each group were treated intraperitoneally with 200 µg of purified MAb m61 or ch61 24 ...
Groups of mice at five animals per group were injected with the indicated amounts of mAb by the intr...
<p>Two-day-old suckling mice (ICR strain) were injected intracranially (i.c.) with 1×10<sup>4</sup> ...
<p>MAb protection activity was determined using the mouse protection assay with 5 estimated MLD<sub>...
<p>Different toxin doses were pre-incubated with combinations of equally diluted MAb ascites fluids ...
<p>BoNT/A (10 LD50) was administered via intra-peritoneal injection to Swiss ...
<p>The human and mouse anti-F1 and anti-V mAbs were given i.p. to mice 24 hrs before parenteral chal...
<p>Mice were passively immunized before (A) or after (B) virus challenge with Aichi (H3) or WSN (H1)...
<p>WT and STAT1<sup>−/−</sup> mice were infected with 10<sup>8</sup> spores <i>B.anthracis</i> intra...
<p>(A–E) Antibody titers elicited by vaccination with DM-C. Six mice per groups were vaccinated with...
Immunoglobulin G3 (IgG3) is the predominant IgG subclass elicited in response to polysaccharide anti...
BALB/c mice were administered (i.p.) once the indicated mAbs (150 μg/mouse in 0.5 mL 0.9% NaCl) or 0...
<p>mAbs were administered by the i.p. route at the doses (µg) listed. Intranasal challenge was perfo...
Bacterial capsules are common targets for antibody-mediated immunity. The capsule of Bacillus anthra...
<p>A/J mice were immunized with either: adjuvant control (*), PA-Av/IFA (○), PA-Av-Alum (□), or PA-A...
<p>Ten mice in each group were treated intraperitoneally with 200 µg of purified MAb m61 or ch61 24 ...
Groups of mice at five animals per group were injected with the indicated amounts of mAb by the intr...
<p>Two-day-old suckling mice (ICR strain) were injected intracranially (i.c.) with 1×10<sup>4</sup> ...
<p>MAb protection activity was determined using the mouse protection assay with 5 estimated MLD<sub>...
<p>Different toxin doses were pre-incubated with combinations of equally diluted MAb ascites fluids ...
<p>BoNT/A (10 LD50) was administered via intra-peritoneal injection to Swiss ...
<p>The human and mouse anti-F1 and anti-V mAbs were given i.p. to mice 24 hrs before parenteral chal...
<p>Mice were passively immunized before (A) or after (B) virus challenge with Aichi (H3) or WSN (H1)...
<p>WT and STAT1<sup>−/−</sup> mice were infected with 10<sup>8</sup> spores <i>B.anthracis</i> intra...
<p>(A–E) Antibody titers elicited by vaccination with DM-C. Six mice per groups were vaccinated with...
Immunoglobulin G3 (IgG3) is the predominant IgG subclass elicited in response to polysaccharide anti...